Neuren Pharmaceuticals
NEU.AX
#5461
Rank
NZ$1.79 B
Marketcap
$13.81
Share price
-9.20%
Change (1 day)
-13.22%
Change (1 year)

EPS for Neuren Pharmaceuticals (NEU.AX)

EPS in 2023: $1.44

According to Neuren Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $1.44. In 2023 the company made an earnings per share (EPS) of $1.44 an increase over its 2022 EPS that were of $0.001740.

EPS history for Neuren Pharmaceuticals from 2002 to 2023

Annual EPS

Year EPS Change
2023$1.4482396.45%
2022$0.001740-102.13%
2021-$0.08155-27.64%
2020-$0.11-12.55%
2019-$0.13-446.24%
2018$0.03722-247.23%
2017-$0.02528-85.3%
2016-$0.17-13.42%
2015-$0.2034.36%
2014-$0.15-47.14%
2013-$0.2883.64%
2012-$0.15-28.56%
2011-$0.21-46.5%
2010-$0.40-3690.16%
2009$0.01110-100.76%
2008-$1.46-38.72%
2007-$2.3811.23%
2006-$2.1414.27%
2005-$1.87-42.59%
2004-$3.262.56%
2003-$3.1836.5%
2002-$2.33